Geographic and Racial/Ethnic Variations in Patterns of Multimorbidity Burden in Patients with Type 2 Diabetes

Journal of General Internal Medicine

Volumn 30, Issue 1, 2015, Pages 25-32

  Lynch, Cheryl P ^a,b   Gebregziabher, Mulugeta ^a,b   Axon, R Neal ^a,b   Hunt, Kelly E ^a,b   Payne, Elizabeth ^a,b   Egede, Leonard E ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

multimorbidity; pattern; racial ethnic; rural residence; veterans

Indexed keywords

ADULT; AGED; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RACE DIFFERENCE; RETROSPECTIVE STUDY; RURAL AREA; URBAN AREA; VETERAN; AFRICAN AMERICAN; AGE; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RURAL HEALTH; UNITED STATES; URBAN HEALTH; VETERANS;

EID: 84943423650     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-2990-y     Document Type: Article

References (39)

1. Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases–a systematic review on existing multimorbidity indices. J Gerontol A, Biol Sci Med Sci. 2011;66(3):301–311.
2. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–2276.
3. Findley P, Shen C, Sambamoorthi U. Multimorbidity and persistent depression among veterans with diabetes, heart disease, and hypertension. Health Soc Work. 2011;36(2):109–119.
4. Teljeur C, Smith SM, Paul G, Kelly A, O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19(1):17–22.
5. Steinman MA, Lee SJ, John Boscardin W, et al. Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc. 2012;60(10):1872–1880.
6. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and Estimates on Diabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services;2011.
7. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51(5):367–375.
8. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract: J Royal Coll Gen Pract. 2011;61(582):e12–21.
9. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.
10. Kadam UT, Croft PR. Clinical multimorbidity and physical function in older adults: a record and health status linkage study in general practice. Fam Pract. 2007;24(5):412–419.
11. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54(7):661–674.
12. Payne RA, Abel GA, Guthrie B, Mercer SW. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. CMAJ: Can Med Assoc J = Journal de l'Association Medicale Canadienne. 2013;185(5):E221–228.
13. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.
14. Mathur R, Hull SA, Badrick E, Robson J. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management. Br J Gen Pract: J Royal Coll Gen Pract. 2011;61(586):e262–270.
15. Lynch CP, Gebregziabher M, Echols C, Gilbert GE, Zhao Y, Egede LE. Racial disparities in all-cause mortality among veterans with type 2 diabetes. J Gen Intern Med. 2010;25(10):1051–1056.
16. Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Med Care. 2010;48(6):527–533.
17. Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care. 2011;34(4):938–943.
18. Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes (February). Ann Pharmacother. 2011;45(2):169–178.
19. Sinnige J, Braspenning J, Schellevis F, Stirbu-Wagner I, Westert G, Korevaar J. The prevalence of disease clusters in older adults with multiple chronic diseases - a systematic literature review. PLoS One. 2013;8(11):e79641.
20. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(Suppl 2):B10–21.
21. West AN, Lee RE, Shambaugh-Miller MD, et al. Defining “rural” for veterans’ healthcare planning. Journal of Rural Health (in press).
22. Department of Veterans Affairs Field Research Advisory Committee. (2004). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. 2004; http://www.research.va.gov/about/frac/FRAC-ops.pdf.
23. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35(12):2533–2539.
24. Egede LE, Lynch CP, Gebregziabher M, et al. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013;28(2):208–215.
25. Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal Effects of Medication Nonadherence on Glycemic Control. Ann Pharmacother. Feb 28 2014.
26. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142–151.
27. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
28. Hilbe JM.Negative Binomial Regression: Cambridge University Press; 2008
29. Vimalananda VG, Miller DR, Christiansen CL, Wang W, Tremblay P, Fincke BG. Cardiovascular disease risk factors among women veterans at VA medical facilities. J Gen Intern Med. 2013;28(Suppl 2):S517–523.
30. Yoon J, Scott JY, Phibbs CS, Frayne SM. Trends in rates and attributable costs of conditions among female VA patients, 2000 and 2008. Womens Health Issues. 2012;22(3):e337–344.
31. Frayne SM, Parker VA, Christiansen CL, et al. Health status among 28,000 women veterans. The VA Women's health program evaluation project. J Gen Intern Med. 2006;21(Suppl 3):S40–46.
32. Piette JD, Kerr E, Richardson C, Heisler M. Veterans affairs research on health information technologies for diabetes self-management support. J Diabetes Sci Technol. 2008;2(1):15–23.
33. Marteau TM, Mann E, Prevost AT, et al. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ. 2010;340:c2138.
34. Orton E, Forbes-Haley A, Tunbridge L, Cohen S. Equity of uptake of a diabetic retinopathy screening programme in a geographically and socio-economically diverse population. Public Health. 2013;127(9):814–821.
35. Bowles KH. Nurse practitioner provided home telemonitoring and medication management improves glycemic control in primary care patients with type 2 diabetes more than monthly care coordination telephone call. Evid-Based Nurs. 2010;13(3):74–75.
36. McFarland M, Davis K, Wallace J, et al. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012;32(5):420–426.
37. Stone RA, Rao RH, Sevick MA, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010;33(3):478–484.
38. Stone RA, Sevick MA, Rao RH, et al. The diabetes telemonitoring study extension: an exploratory randomized comparison of alternative interventions to maintain glycemic control after withdrawal of diabetes home telemonitoring. J Am Med Inform Assoc: JAMIA. 2012;19(6):973–979.
39. Cornell JE, Pugh JA, Williams JW, et al. Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database. Appl Multivar Res. 2007;12(3):163–182.